Teladoc Health (TDOC)
(Delayed Data from NYSE)
$8.75 USD
-0.43 (-4.68%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $8.77 +0.02 (0.23%) 7:58 PM ET
3-Hold of 5 3
A Value A Growth F Momentum A VGM
Cash flow Statements
Fiscal Year End for Teladoc Health, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -220.37 | -13,659.53 | -428.79 | -485.14 | -98.86 |
Depreciation/Amortization & Depletion | 354.72 | 13,676.80 | 280.87 | 123.38 | 70.39 |
Net Change from Assets/Liabilities | 11.64 | -60.97 | -50.32 | -90.48 | -0.16 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 204.02 | 232.99 | 392.23 | 398.73 | 58.50 |
Net Cash From Operating Activities | 350.02 | 189.29 | 193.99 | -53.51 | 29.87 |
Property & Equipment | -156.35 | -172.76 | -63.93 | -26.04 | -10.90 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | -78.66 | -567.43 | -11.19 |
Investments | 0.00 | 2.51 | 60.90 | 2.50 | 47.10 |
Other Investing Activities | 0.00 | 2.51 | 8.72 | 0.00 | 0.00 |
Net Cash from Investing Activities | -156.35 | -167.74 | -72.98 | -590.98 | 25.01 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 11.13 | 12.39 | 42.59 | 59.04 | 36.66 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | -0.14 | 853.51 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -0.28 | -5.89 | -1.51 | -53.41 | -1.57 |
Net Cash from Financing Activities | 10.85 | 6.50 | 40.95 | 859.14 | 35.09 |
Effect of Exchange Rate Changes | 0.97 | -3.34 | -1.80 | 4.32 | 0.39 |
Net Change In Cash & Equivalents | 205.49 | 24.70 | 160.16 | 218.97 | 90.36 |
Cash at Beginning of Period | 918.18 | 893.48 | 733.32 | 514.35 | 423.99 |
Cash at End of Period | 1,123.68 | 918.18 | 893.48 | 733.32 | 514.35 |
Diluted Net EPS | -1.34 | -84.60 | -2.73 | -5.36 | -1.38 |
Fiscal Year End for Teladoc Health, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -919.56 | -81.89 | -220.37 | -191.48 | -134.41 |
Depreciation/Amortization & Depletion | 989.36 | 100.51 | 354.72 | 252.39 | 154.04 |
Net Change from Assets/Liabilities | -61.50 | -51.91 | 11.64 | 0.78 | -11.12 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 89.31 | 42.21 | 204.02 | 158.26 | 105.82 |
Net Cash From Operating Activities | 97.60 | 8.92 | 350.02 | 219.94 | 114.34 |
Property & Equipment | -63.26 | -35.51 | -156.35 | -119.84 | -82.19 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | -109.78 | 0.00 |
Net Cash from Investing Activities | -63.26 | -35.51 | -156.35 | -119.84 | -82.19 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 5.48 | 1.65 | 11.13 | 10.02 | 6.11 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 0.08 | 0.10 | -0.28 | 2.61 | 1.45 |
Net Cash from Financing Activities | 5.56 | 1.75 | 10.85 | 12.63 | 7.56 |
Effect of Exchange Rate Changes | -1.19 | -0.90 | 0.97 | -0.38 | 0.81 |
Net Change In Cash & Equivalents | 38.71 | -25.74 | 205.49 | 112.35 | 40.51 |
Cash at Beginning of Period | 1,123.68 | 1,123.68 | 918.18 | 918.18 | 918.18 |
Cash at End of Period | 1,162.38 | 1,097.94 | 1,123.68 | 1,030.53 | 958.70 |
Diluted Net EPS | -4.92 | -0.49 | -0.17 | -0.35 | -0.40 |